+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 142 Pages
  • May 2023
  • Region: Global
  • IMARC Group
  • ID: 5820546
Description Jump to:
The global breast cancer liquid biopsy market size reached US$ 110.7 Million in 2022. Looking forward, the publisher expects the market to reach US$ 326.2 Million by 2028, exhibiting a growth rate (CAGR) of 17.81% during 2023-2028.

Breast cancer liquid biopsy refers to a non-invasive medical procedure that utilizes blood as a sample for the identification of tumor markers. It assists in evaluating the progression of breast cancer disease and detects Epidermal Growth Factor Receptor (EGFR) gene mutations that help clinicians in choosing the best course of action at the right time. Some of the common biomarkers that are used in this process include circulating tumor cells (CTC), extracellular vesicles, circulating tumor DNA, etc. Breast cancer liquid biopsy offers several benefits, including minimal invasiveness, characterization of new lesions, drug and therapeutic target identifications for cancer treatment, etc.

Breast Cancer Liquid Biopsy Market Trends:

The growing prevalence of breast cancer along with the escalating demand for non-invasive medical procedures is primarily driving the global breast cancer liquid biopsy market. In addition to this, the rising consumer awareness towards numerous benefits associated with the liquid biopsy technique, including quicker results, lower cost, minimal health risk, non-invasiveness, etc., is also augmenting the market growth. Moreover, various global organizations are conducting awareness campaigns to educate individuals about breast health and cancer diagnostic measures. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer biopsy and other related medical procedures, is creating a positive outlook for the market. Apart from this, numerous manufacturers are making significant investments in the introduction of advanced biopsy techniques that enables the enhancement of several aspects of breast cancer management, such as prediction of prognosis, early diagnosis of relapse, serial sampling, efficient longitudinal monitoring of disease progress and response to treatment, etc. Furthermore, the emerging trend of personalized therapeutics coupled with the widespread adoption of polymerase chain reaction (PCR) and next-generation sequencing (NGS) for cancer detection will continue to drive the global breast cancer liquid biopsy market in the coming years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global breast cancer liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product services, circulating biomarker and end user.

Breakup by Product Services:

  • Reagent Kits
  • Instruments
  • Services

Breakup by Circulating Biomarker:

  • Circulating Tumor Cells (CTCs)
  • Cell-Free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Others

Breakup by End User:

  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Others

Breakup by Region:

North America

  • United States
  • Canada

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others

Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocept Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Menarini Silicon Biosystems (The Menarini Group), NeoGenomics Laboratories Inc., Qiagen and Sysmex Europe SE (Sysmex Corporation).

Key Questions Answered in This Report:

  • What was the size of the global breast cancer liquid biopsy market in 2022?
  • What is the expected growth rate of the global breast cancer liquid biopsy market during 2023-2028?
  • What has been the impact of COVID-19 on the global breast cancer liquid biopsy market?
  • What are the key factors driving the global breast cancer liquid biopsy market?
  • What is the breakup of the global breast cancer liquid biopsy market based on the product services?
  • What are the key regions in the global breast cancer liquid biopsy market?
  • Who are the key players/companies in the global breast cancer liquid biopsy market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Breast Cancer Liquid Biopsy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Services
6.1 Reagent Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Circulating Biomarker
7.1 Circulating Tumor Cells (CTCs)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell-Free DNA (cfDNA)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Extracellular Vesicles (EVs)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Reference Laboratories
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals and Physician Laboratories
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Biocept Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bio-Rad Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 F. Hoffmann-La Roche AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Fluxion Biosciences Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Guardant Health Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Illumina Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Menarini Silicon Biosystems (The Menarini Group)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 NeoGenomics Laboratories Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Qiagen
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sysmex Europe SE (Sysmex Corporation)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
List of Figures
Figure 1: Global: Breast Cancer Liquid Biopsy Market: Major Drivers and Challenges
Figure 2: Global: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Breast Cancer Liquid Biopsy Market: Breakup by Product Services (in %), 2022
Figure 5: Global: Breast Cancer Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
Figure 6: Global: Breast Cancer Liquid Biopsy Market: Breakup by End User (in %), 2022
Figure 7: Global: Breast Cancer Liquid Biopsy Market: Breakup by Region (in %), 2022
Figure 8: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Breast Cancer Liquid Biopsy (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Breast Cancer Liquid Biopsy (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Breast Cancer Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Breast Cancer Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Breast Cancer Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Breast Cancer Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Breast Cancer Liquid Biopsy Industry: SWOT Analysis
Figure 78: Global: Breast Cancer Liquid Biopsy Industry: Value Chain Analysis
Figure 79: Global: Breast Cancer Liquid Biopsy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Breast Cancer Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Product Services (in Million US$), 2023-2028
Table 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
Table 4: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Breast Cancer Liquid Biopsy Market: Competitive Structure
Table 7: Global: Breast Cancer Liquid Biopsy Market: Key Players

Companies Mentioned

  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Fluxion Biosciences Inc.
  • Guardant Health Inc.
  • Illumina Inc.
  • Menarini Silicon Biosystems (The Menarini Group)
  • NeoGenomics Laboratories Inc.
  • Qiagen and Sysmex Europe SE (Sysmex Corporation)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages142
PublishedMay 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 110.7 Million
Forecasted Market Value ( USD ) by 2028 $ 326.2 Million
Compound Annual Growth Rate19.7%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Forecast 2024-2030 - Product Image

Global Breast Cancer Liquid Biopsy Market by Biomarker (Cell-free DNA, Circulating Tumor Cells, Extracellular Vesicles), End-User (Hospitals & Physician Laboratories, Reference Laboratories) - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Global Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Forecast 2024-2030 - Product Image

Global Breast Cancer Liquid Biopsy Testing Devices Market by Offerings (Assay & Reagents Kits, Instruments), Circulating Biomarker (Circulating Tumar DNA, Circulating Tumor Cell, Extracellular Vesicles), End-User, Appplication - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Breast Cancer Liquid Biopsy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Breast Cancer Liquid Biopsy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 107 Pages
  • Global
From
Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 143 Pages
  • Global
From
Breast Cancer Liquid Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Breast Cancer Liquid Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.